To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older
Clinical trial NCT00082095 · TERMINATED
Trial details
- NCT number
- NCT00082095
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-01
- Primary completion
- 2005-12-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.